CN Patent

CN103788166A — △13（18）-cddo衍生物、其制备方法与在制药中的用途

Assigned to China Pharmaceutical University · Expires 2014-05-14 · 12y expired

What this patent protects

本发明涉及药物领域，具有涉及一种式I所示的齐墩果酸衍生物及药学上可接受的盐、其制备方法和医药用途，属于生物医药领域。本发明化合物的制备方法不仅条件温和，而且操作简单，收率较高，同时还具有很强的实用性。药理实验结果表明，本发明具有优良的抗炎，抗肿瘤活性，临床上可作为各种炎症引起的疾病和肿瘤的治疗药物应用。

USPTO Abstract

本发明涉及药物领域，具有涉及一种式I所示的齐墩果酸衍生物及药学上可接受的盐、其制备方法和医药用途，属于生物医药领域。本发明化合物的制备方法不仅条件温和，而且操作简单，收率较高，同时还具有很强的实用性。药理实验结果表明，本发明具有优良的抗炎，抗肿瘤活性，临床上可作为各种炎症引起的疾病和肿瘤的治疗药物应用。

Drugs covered by this patent

Patent Metadata

Patent number
CN103788166A
Jurisdiction
CN
Classification
—
Expires
2014-05-14
Drug substance claim
No
Drug product claim
No
Assignee
China Pharmaceutical University
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.